These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1810941

  • 21. Stereospecific synthesis of chiral metabolites of ifosfamide and their determination in the urine.
    Misiura K, Okruszek A, Pankiewicz K, Stec WJ, Czownicki Z, Utracka B.
    J Med Chem; 1983 May; 26(5):674-9. PubMed ID: 6842506
    [Abstract] [Full Text] [Related]

  • 22. The effect of route of administration and fractionation of dose on the metabolism of ifosfamide.
    Lind MJ, Roberts HL, Thatcher N, Idle JR.
    Cancer Chemother Pharmacol; 1990 May; 26(2):105-11. PubMed ID: 2347037
    [Abstract] [Full Text] [Related]

  • 23. Simultaneous determination of N,N',N"-triethylenethiophosphoramide, cyclophosphamide and some of their metabolites in plasma using capillary gas chromatography.
    Huitema AD, Tibben MM, Kerbusch T, Zwikker JW, Rodenhuis S, Beijnen JH.
    J Chromatogr B Biomed Sci Appl; 1998 Sep 25; 716(1-2):177-86. PubMed ID: 9824231
    [Abstract] [Full Text] [Related]

  • 24. Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma.
    Kerbusch T, Mathĵt RA, Keizer HJ, Ouwerkerk J, Rodenhuis S, Schellens JH, Beijnen JH.
    Eur J Clin Pharmacol; 2001 Sep 25; 57(6-7):467-77. PubMed ID: 11699611
    [Abstract] [Full Text] [Related]

  • 25. Determination of 4-hydroxyifosfamide concomitantly with ifosfamide and its dechloroethylated metabolites using gas chromatography and a nitrogen phosphorus-selective detector.
    Gourmel B, Granvil CP, Denis SL, Wainer IW, Bousquet B.
    J Chromatogr B Biomed Sci Appl; 1999 Sep 10; 732(1):3-15. PubMed ID: 10517217
    [Abstract] [Full Text] [Related]

  • 26. [Isolation and characterisation of two main metabolites of ifosfamide from human urine (author's transl)].
    Norpoth K, Müller G, Raidt H.
    Arzneimittelforschung; 1976 Sep 10; 26(7):1376-7. PubMed ID: 1036928
    [Abstract] [Full Text] [Related]

  • 27. The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.
    Singer JM, Hartley JM, Brennan C, Nicholson PW, Souhami RL.
    Br J Cancer; 1998 Mar 10; 77(6):978-84. PubMed ID: 9528844
    [Abstract] [Full Text] [Related]

  • 28. Biomonitoring of pharmacists and nurses at occupational risk from handling antineoplastic agents.
    Santos AN, Oliveira RJ, Pessatto LR, Gomes RDS, Freitas CAF.
    Int J Pharm Pract; 2020 Oct 10; 28(5):506-511. PubMed ID: 31663186
    [Abstract] [Full Text] [Related]

  • 29. [Solid phase-sample preparation of ifosfamide and chloroethyl metabolites in biological material. 1. Determination in plasma and urine].
    Hennig B, Rädler S, Blaschke G, Boos J.
    Pharmazie; 1992 Oct 10; 47(10):783-7. PubMed ID: 1480658
    [Abstract] [Full Text] [Related]

  • 30. Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.
    Manz I, Dietrich I, Przybylski M, Niemeyer U, Pohl J, Hilgard P, Brock N.
    Biomed Mass Spectrom; 1985 Sep 10; 12(9):545-53. PubMed ID: 2932183
    [Abstract] [Full Text] [Related]

  • 31. Determination of ifosfamide, 2- and 3-dechloroethyifosfamide using gas chromatography with nitrogen-phosphorus or mass spectrometry detection.
    Kerbusch T, Jeuken MJ, Derraz J, van Putten JW, Huitema AD, Beijnen JH.
    Ther Drug Monit; 2000 Oct 10; 22(5):613-20. PubMed ID: 11034269
    [Abstract] [Full Text] [Related]

  • 32. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.
    Sottani C, Rinaldi P, Leoni E, Poggi G, Teragni C, Delmonte A, Minoia C.
    Rapid Commun Mass Spectrom; 2008 Sep 10; 22(17):2645-59. PubMed ID: 18666202
    [Abstract] [Full Text] [Related]

  • 33. [Metabolism of enantiomers of the cytostatic ifosfamide].
    Blaschke G, Widey W.
    Arzneimittelforschung; 1989 Feb 10; 39(2):223-6. PubMed ID: 2730691
    [Abstract] [Full Text] [Related]

  • 34. [The determination of urinary cyclophosphamide at low concentration levels by liquid-liquid extraction and HPLC/MS/MS analysis].
    Sottani C, Turci R, Perbellini L, Minoia C.
    G Ital Med Lav Ergon; 1998 Feb 10; 20(4):239-42. PubMed ID: 9987616
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamide.
    Kaijser GP, Keizer HJ, Beijnen JH, Bult A, Underberg WJ.
    Anticancer Res; 1996 Feb 10; 16(5B):3247-57. PubMed ID: 8920799
    [Abstract] [Full Text] [Related]

  • 36. Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma.
    Boddy AV, Idle JR.
    J Chromatogr; 1992 Mar 13; 575(1):137-42. PubMed ID: 1517290
    [Abstract] [Full Text] [Related]

  • 37. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
    Kurowski V, Wagner T.
    Cancer Chemother Pharmacol; 1997 Mar 13; 39(5):431-9. PubMed ID: 9054957
    [Abstract] [Full Text] [Related]

  • 38. Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys.
    Arndt CA, Balis FM, McCully CL, Colvin OM, Poplack DG.
    Cancer Res; 1988 Apr 15; 48(8):2113-5. PubMed ID: 3349482
    [Abstract] [Full Text] [Related]

  • 39. [Fluorometric determination of "activated" cyclophosphamide and ifosfamide in blood (author's transl)].
    Voelcker G, Haeglsperger R, Hohorst HJ.
    J Cancer Res Clin Oncol; 1979 Apr 12; 93(3):233-40. PubMed ID: 468886
    [Abstract] [Full Text] [Related]

  • 40. [Prophylactic alkalization of the urine during cytostatic tumor treatment with the oxazaphosphorine derivatives, cyclophosphamide and ifosfamide].
    Brühl P, Hoefer-Janker H, Scheef W, Vahlensieck W.
    Onkologie; 1979 Jun 12; 2(3):120-4. PubMed ID: 42866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.